Upcoming Conferences Showcase Voyager Therapeutics' Innovations

Voyager Therapeutics' Upcoming Conference Participation

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a pioneering biotechnology company focused on utilizing genetic technology to address neurological disorders, has announced its involvement in several significant investor conferences. These forums will provide a platform for Voyager to present its innovative approaches and advancements in the field of gene therapy.

Highlighting Innovative Treatments

During these conferences, Voyager aims to shed light on crucial preclinical data that underscores the efficacy of its non-viral delivery system. This technology employs novel receptor-binding molecules that facilitate the transport of neurotherapeutics across the blood-brain barrier, an essential aspect in treating conditions such as Alzheimer's disease, Parkinson's disease, and ALS.

Citi's 2025 Biopharma Back to School Conference

One of the highlighted events is the Citi's 2025 Biopharma Back to School Conference. Here, Voyager will engage in a fireside chat scheduled for 4:00 p.m. ET, where they will discuss their cutting-edge research and development strategies.

Wells Fargo Healthcare Conference

The Wells Fargo Healthcare Conference, taking place shortly after, will see Voyager present at 4:30 p.m. ET. This is another wonderful opportunity for the company to connect with investors and industry experts alike.

Further Conference Engagements

The company will also partake in key discussions at numerous other conferences, including the:

• Cantor Global Healthcare Conference 2025: A fireside chat is set for 1:35 p.m. ET.
• Morgan Stanley 23rd Annual Global Healthcare Conference: One-on-one meetings available throughout the day.
• Baird 2025 Global Healthcare Conference: Fireside chat at 9:05 a.m. ET.
• H.C. Wainwright 27th Annual Global Investment Conference: Scheduled for 2:30 p.m. ET.

Webcasts and Future Investors

For those unable to attend in person, webcasts of the fireside chats at both the Citi and Baird conferences will be available online. Investors can access these sessions from the Investors section of Voyager's website, with replays accessible for at least 30 days following the events.

About Voyager Therapeutics

Founded with the mission to revolutionize the treatment of debilitating neurological diseases, Voyager Therapeutics (NASDAQ: VYGR) utilizes advanced genetic insights to create therapies that aim not only to alleviate symptoms but to address the root causes of these conditions. Their development pipeline includes potential treatments for various illnesses, showcasing their commitment to innovative healthcare solutions.

Contacting Voyager Therapeutics

Voyager Therapeutics encourages inquiries from interested stakeholders. For investor relations, contact Trista Morrison at tmorrison@vygr.com. Media inquiries can be directed to Adam Silverstein at adam@scientpr.com, ensuring everyone has access to the latest information regarding their breakthroughs and corporate activities.

Frequently Asked Questions

What is Voyager Therapeutics focused on?

Voyager Therapeutics specializes in genetic treatments for neurological diseases, aiming to modify and potentially cure these conditions.

When is Voyager participating in the Citi Conference?

Voyager will participate in the Citi Conference on September 2nd at 4:00 p.m. ET.

How can I access the webcasts from the conferences?

Webcasts can be found in the Investors section of Voyager's website and will be archived for 30 days.

Who can I contact for more information about Voyager Therapeutics?

For investor relations, reach out to Trista Morrison via email at tmorrison@vygr.com.

What advancements will Voyager showcase at the conferences?

Voyager will highlight its non-viral delivery platform and the data supporting its application in neurotherapeutics.

About The Author

Hi there, As a writer and financial specialist, Henry Turner is passionate about guiding people through the complex world of finance. Having worked in finance for many years, I am an expert at simplifying difficult financial ideas into understandable, useful insights for my blog and articles. My goal is to arm you with the confidence and information you need to make wise financial choices.

Writing for a number of financial blogs has allowed me to interact with readers from novice investors looking for fresh ideas to seasoned investors starting their financial journeys. My mission is to enable everyone to understand and access finance, so enabling you to confidently and clearly reach your financial goals. I appreciate you traveling with me toward success and financial literacy.

Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.